The postsynaptic actions of acetylcholine, adenosine, yaminobutyric acid, histamine, norepinephrine, and serotonin were analyzed in human cortical pyramidal cells maintained in vitro. The actions of these six putative neurotransmitters converged onto three distinct potassium currents.
Inhibition of neuronal firing was elicited by adenosine, baclofen (a yaminobutyric acid type B receptor agonist), or serotonin and appeared to be due to an increase in the same potassium current by all three agents. These data reveal that individual neuronal currents in the human cerebral cortex are under the control of several putative neurotransmitters and that each neurotransmitter may exhibit more than one postsynaptic action. The specific anatomical connections of these various neurotransmitter systems, as well as their heterogeneous distribution of postsynaptic receptors and responses, allows each to make a specific contribution to the modulation of cortical activity.
Human cerebral cortical activity may be under the influence of a large number of neuroactive substances, including acetylcholine (ACh), adenosine, 'y-aminobutyric acid (GABA), histamine, norepinephrine, and serotonin (5-HT) (1) (2) (3) (4) (5) (6) (7) (8) . The postsynaptic actions of these putative neurotransmitters in human neocortical neurons are largely unknown, although the demonstration of muscarinic receptor-mediated block of the voltage-and time-dependent K+ current known as Mcurrent (IM) is a notable exception (2) . Investigations of neurotransmitter actions in nonhuman subcortical neurons have revealed a wide variety of postsynaptic responses as well as a remarkable convergence and divergence of neurotransmitter action (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . For example, individual neurons in the rodent hippocampus, thalamus, and substantia nigra respond to more than one putative neurotransmitter with the same ionic response (12, 17, (20) (21) (22) . Conversely, a single neurotransmitter, such as acetylcholine, can elicit markedly different ionic responses in separate brain regions and even in distinct morphological cell classes in the same nucleus (e.g., refs. 15 and 19) .
Convergence and divergence of neurotransmitter action has important implications for understanding functional systems in the brain. Not only do the neuronal systems underlying behavior consist of a number of transmitter pathways, but each pathway is involved in more than one functional system (e.g., ref. 22 ). In addition, many neurological disorders, such as Parkinson, Alzheimer, and Huntington diseases and, perhaps, epilepsy, are expressed as a loss or dysfunction in one or more neurotransmitter system. Interactions of neurotransmitters may allow for subtleties in neuronal modulation that are important for understanding these profound neurological deficits.
In the present experiments we show that multiple neurotransmitters are involved in determining the amplitude of individual currents and, therefore, the electrophysiological behavior of human neocortical neurons.
METHODS
Human neocortical tissue used was a small portion of that which is normally removed for the treatment of intractable epilepsy. In the majority (71%) of cases, the tissue was obtained from the lateral portions of the anterior temporal lobe in patients in which focal epileptiform activity was localized with chronic depth electrodes to more mesial structures (e.g., hippocampus). This neocortical tissue was not grossly abnormal when examined histologically and did not give rise to abnormal synchronous discharges when maintained in vitro. The extent to which the present results are affected by the patient's history of epilepsy is not known.
Neocortical tissue was resected en bloc by the neurosurgeon (Dennis Spencer, Yale University School of Medicine), and a small portion was placed in 50C bathing medium. In addition, some experiments were performed on anterior cingulate, sensorimotor, or temporal cortical tissue obtained from guinea pigs. These animals were deeply anesthetized with sodium pentobarbital (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) mg/kg i.p.) and decapitated. Four-hundred-micrometer slices were prepared on a Vibratome and maintained at the gas/liquid interface in a recording chamber at 35 ± 10C (23 ether)-N,N,N N'-tetraacetic acid (EGTA) and all other drugs were obtained from Sigma. All agonists were applied in volumes of 5-20 pl by using the pressure-pulse technique (23) .
RESULTS
Stable intracellular recordings were obtained from 110 human and 82 guinea pig cortical neurons for periods of up to 6 hr each. A representative sample of human cortical cells yielded an average resting membrane potential of -81 + 8 mV (SD; n = 22), action potential amplitude of 102 ± 12 mV, and apparent input resistance of 43 ± 10 MO. The electrophysiological properties of neurons studied here indicated that they were most likely pyramidal in morphology (23, 24) .
Reduction of Spike-Frequency Adaptation. Intracellular injection of a suprathreshold depolarizing current pulse resulted in a train of action potentials that showed marked spikefrequency adaptation (Fig. 1, control) . Extracellular application of ACh (1-5 mM in micropipette), or the muscarinic agonist acetyl-3-methylcholine (MCh; 1 mM), resulted in a slow depolarization of the membrane potential and a substantial reduction in spike-frequency adaptation, even after the membrane potential was manually repolarized to the preapplication level ( Fig. 1B ; n = 7, human; n = 3, guinea pig). Similarly, application of norepinephrine (500 ,uM; n = 7, human; n = 15, guinea pig), histamine (500 ,uM; n = 6, human; n = 11, guinea pig) and 5-HT (300-500 AM; n = 4, human; n = 6, guinea pig) also greatly reduced spike-frequency adaptation ( Fig. 1 A, C, and D). However, norepinephrine never, and histamine and 5-HT only occasionally, depolarized the baseline membrane potential (data not shown).
Spike-frequency adaptation results, in part, from the activation of two separate K+ currents: IAHP and IM (25) . IAHP is activated by increases in the intracellular concentration of unbound Ca2l and underlies the slow afterhyperpolarization (hence its name) occurring after a train of action potentials (26) . IAHp was investigated by injecting a depolarizing current pulse (0.8-1.0 nA; 300 msec), which elicited from 6-15 action potentials in normal medium or after a single Ca2l-dependent action potential in medium containing 1 AM tetrodotoxin and 5 mM tetraethylammonium. At the termination of the current pulse, the neuron was voltage clamped (typically at -60 mV), and the amplitude and time course of the after current was examined ( Fig. 1 E-H ). Individual trains of action potentials in normal bathing medium were followed by a slow outward current that possessed an average reversal potential of -100 ± 6 mV (n = 8). Decay of the later portions of IAHP was well fit (r > 0.98) by a single exponential function with an average time constant of 996 ± 382 msec; n = 5 (26) .
Separate applications of MCh, norepinephrine, histamine, and 5-HT all substantially reduced or abolished the slow afterhyperpolarization and/or IAHp (n = 41, human; n = 63, guinea pig), even in the same neuron ( Fig. 1 E-H ; n = 2, human; n = 5, guinea pig). This convergence onto IAHP occurred through four distinct postsynaptic receptors. Block of three of the four receptor subtypes involved in guinea pig neurons by adding the muscarinic antagonist scopolamine ( 1 AM; n = 9), the (3-adrenergic antagonist propranolol (20 AtM; n = 11), the 5-HT antagonist methysergide (5 AM; n = 8) or the H2 histaminergic antagonist cimetidine (10-20 tkM; n = 11) to the bathing medium prevented reduction of IAHp by stimulation of all but the unblocked receptor.
Reduction of IM. IM also contributes to spike-frequency adaptation (2, 27) . The possibility that ACh, histamine, norepinephrine, and 5-HT may suppress IM was therefore examined. Application of MCh to all neurons and 5-HT to middle-layer cells, after depolarization with intracellular injection of current to near-firing threshold (e.g., -60 mV) resulted in a slow depolarization and a decrease in apparent membrane conductance ( Histamine and MCh both caused, in addition, an apparent inward current and, therefore, the traces in E and F were offset to match the predrug baseline for illustrative purposes. IAHP became progressively smaller throughout the course of the experiment due, in part, to repeated applications ofthe four agents. All data, except C, were obtained from the same layer III human cortical neuron from the anterior temporal lobe. Although this cell displayed a reduction in spike-frequency adaptation to norepinephrine, this data was not suitable for illustration due to filtering for examination of IAHP. Data in C was obtained from another anterior temporal human cortical neuron. Under voltage-clamp conditions, MCh (n = 21, human) or 5-HT (n = 6, human) caused a large apparent inward current, lasting from 5-15 min, that resulted from a suppression of IM (Fig. 2 C-I) . The marked voltage dependence of this effect is well illustrated in I-V plots obtained before and during MCh and 5-HT (Fig. 2 G, H, and I) . Under these conditions, MCh and 5-HT both induced a marked inward shift of the I-V relation at membrane potentials positive to approximately -70 mV (Fig. 2 G, H, and I) . In some neurons, there also appeared to be a smaller, relatively linear inward component A 12 Proc. Natl. Acad. Sci. USA 86 (1989) of the MCh and 5-HT responses. This component reversed at -108 ± 4 mV (n = 3, human).
Subtracting the current traces associated with the voltage steps between -45 and -60 mV before and after MCh or 5-HT revealed three components that can be explained as suppression of IM (Fig. 2 E and F, differences a-c) . The reduction in instantaneous "leak" current associated with the voltage jump from -45 to -60 mV represents a reduction in the amount of IM active at -45 mV (Fig. 2 E and F,  difference a) . The slow apparent inward current seen after stepping from -45 to -60 mV represents the deactivation or "turning off" of that portion of IM suppressed by MCh and 5-HT (Fig. 2 Eand F, difference b) , whereas the slow outward Proc. Natl. Acad. Sci. USA 86 (1989) 8101 current seen when stepping from -60 to -45 mV represents the activation of that same portion of IM (Fig. 2 E and F, labeled difference c).
The suppression of IM by 5-HT is not mediated by muscarinic receptors because local application of scopolamine (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) gM, n = 3, human) completely blocked the response to MCh but did not alter that to 5-HT. This effect is not due to the suppression of a Ca2l or Na'-activated potassium current (28) because it persisted in neurons recorded for more than an hour with electrodes containing high concentrations of the Ca2+-chelating substances BAPTA (0.2 M) or EGTA (0.5 M) (n = 3, human) as well as after application of tetrodotoxin (10 gM; n = 3, human). In addition, application of norepinephrine, which potently blocks IAHP, did not result in any reduction of IM (n = 6, human).
Increase in Membrane Potassium Conductance. Application of adenosine (2 mM in micropipette; n = 10, human; n = 11, guinea pig), the GABAB receptor agonist baclofen (100 gM; n = 17, human; n = 8, guinea pig), and in some neurons, 5-HT (n = 14/30, human; n = 13/21, guinea pig) resulted in a hyperpolarization or an outward current and an increase in membrane conductance (Fig. 3) . The average reversal potential for this response, determined from I-V relationships (Fig. 3A) , was similar for all three agents (adenosine: -106 + 6 mV, n = 6; baclofen: -104 ± 7 mV, n = 14; 5-HT: -101 4 mV, n = 8).
In neurons of the rodent hippocampus and brainstem maximal activation of an outward K+ current by baclofen dramatically reduces the outward current induced by 5-HT, and vice versa (20, 21) . Similarly, we found that baclofen reversibly reduced the adenosine-induced current by 85 + 18%; (n = 4, human; n = 4, guinea pig) and the 5-HT-induced current by 95 ± 9% (n = 3, human; Fig. 3 Bl and B2). This nonadditivity suggests convergence of these three agents onto the same potassium current (12, 17) .
Local application of the GABAB antagonist phaclofen (5 mM in micropipette) resulted in a substantial (60%) decrease in the response to baclofen, but not adenosine (n = 4). Local application of the 5-HT1A partial agonist 8-hydroxydipropylaminotetralin (500 ,uM), on the other hand, resulted in a small hyperpolarization and increase in membrane conductance (n A = 3, human; n = 3, guinea pig). In addition, local application of 8-hydroxydipropylaminotetralin also resulted in a reduction, or block, of the hyperpolarizing response to 5-HT and the appearance, or enhancement, of a 5-HT-induced slow depolarization (data not shown; n = 2, human; n = 2, guinea pig). These results indicate that baclofen is causing an increase in membrane potassium conductance through GABAB receptors, whereas 5-HT is doing so through the 5-HT1A receptor subtype. Anatomic Distribution of Neurotransmnitter Responses. The ionic responses to ACh, adenosine, baclofen, histamine, and norepinephrine detailed above appeared to be present in all, or nearly all, presumed pyramidal neurons that we tested in layers II-III and V of the anterior temporal, occipital, and frontal human cortical regions. However, this is not to say that significant laminar and area differences do not exist (for example, see ref. 29) . Indeed, the responses to 5-HT, although consistent between applications in the same neuron, varied significantly between different cells. The 5-HT-induced hyperpolarization and outward current was prominent in layer II and V neurons, whereas the suppression of IM appeared to be more prominent in neurons located in midcortical lamina. 5-HT-induced suppression of IAHP was present in all neurons tested, regardless of laminar position.
Further experiments on possible laminar and area differences in transmitter actions would be worthwhile. DISCUSSION Anatomical and psychopharmacological data suggests that the excitability of neurons in human cerebral cortex is under the control of cholinergic, GABAergic, histaminergic, noradrenergic, purinergic, and serotonergic neurotransmitter systems (1) (2) (3) (4) (5) (6) (7) (8) . Our data reveal that the neurotransmitters and/or neuromodulators thought to be released by these systems have potent and long-lasting effects on specific ionic currents in human cortical pyramidal cells. ACh, histamine, norepinephrine, and 5-HT are potent blockers of spikefrequency adaptation, an effect that results, in part, from a reduction of two specialized K+ currents: IAHP (blocked by all four agents) and IM (blocked by ACh and 5-HT) (Figs. 1, We term this potassium current IKG because of its association with G proteins in many neuronal systems (12, 17, 20) and to distinguish it from other potassium currents. Stimulation of 5-HT and muscarinic receptors results in suppression of IM. Only activation of GABAA receptors is found to increase membrane chloride conductance (8 
